Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
UCB at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
UCB takes part in 2 sessions at Biomarkers Europe 2026 in Basel. Its sessions centre on AI in drug development, from computational pathology across the pipeline to safety testing before human trials. One reviews how AI has been used in that safety work so far and how far it still has to go.
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
UCB Brussels, Belgium | |
Belgian biopharmaceutical company with marketed medicines in immunology and neurology, including epilepsy and autoimmune diseases. | Panel Wed Oct 14 1:00pm–1:30pm Deploying Computational Pathology Across The Pharma Pipeline Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Talk Wed Oct 14 3:40pm–4:05pm Artificial Intelligence For Non-Clinical Safety: Past, Present And The Long Road Ahead Multimodal & AI-enabled precision medicine |
Instantly find 20 buyers from UCB
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction